CO2022005947A2 - Formulaciones de cápsulas de gelatina blanda no animales, métodos de preparación y métodos de uso de las mismas - Google Patents

Formulaciones de cápsulas de gelatina blanda no animales, métodos de preparación y métodos de uso de las mismas

Info

Publication number
CO2022005947A2
CO2022005947A2 CONC2022/0005947A CO2022005947A CO2022005947A2 CO 2022005947 A2 CO2022005947 A2 CO 2022005947A2 CO 2022005947 A CO2022005947 A CO 2022005947A CO 2022005947 A2 CO2022005947 A2 CO 2022005947A2
Authority
CO
Colombia
Prior art keywords
methods
preparation
gelatin capsule
soft gelatin
capsule formulations
Prior art date
Application number
CONC2022/0005947A
Other languages
English (en)
Spanish (es)
Inventor
Qi Fang
Keith Tanner
Karunakar Sukruru
Aristippos Gennadios
Original Assignee
Scherer Technologies Llc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Llc R P filed Critical Scherer Technologies Llc R P
Publication of CO2022005947A2 publication Critical patent/CO2022005947A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A45—HAND OR TRAVELLING ARTICLES
    • A45D—HAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
    • A45D37/00—Sachet pads specially adapted for liquid toiletry or cosmetic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
CONC2022/0005947A 2019-10-09 2022-05-06 Formulaciones de cápsulas de gelatina blanda no animales, métodos de preparación y métodos de uso de las mismas CO2022005947A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962912886P 2019-10-09 2019-10-09
PCT/US2020/054806 WO2021072092A1 (en) 2019-10-09 2020-10-08 Non-animal softgel capsule formulations, methods of preparation, and methods of use thereof

Publications (1)

Publication Number Publication Date
CO2022005947A2 true CO2022005947A2 (es) 2022-07-29

Family

ID=75438053

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2022/0005947A CO2022005947A2 (es) 2019-10-09 2022-05-06 Formulaciones de cápsulas de gelatina blanda no animales, métodos de preparación y métodos de uso de las mismas

Country Status (14)

Country Link
US (1) US20240091161A1 (cg-RX-API-DMAC7.html)
EP (1) EP4041022A4 (cg-RX-API-DMAC7.html)
JP (2) JP7727623B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220080130A (cg-RX-API-DMAC7.html)
CN (1) CN114667084B (cg-RX-API-DMAC7.html)
AR (1) AR122316A1 (cg-RX-API-DMAC7.html)
AU (1) AU2020363824B2 (cg-RX-API-DMAC7.html)
BR (1) BR112022005755A2 (cg-RX-API-DMAC7.html)
CA (1) CA3155876A1 (cg-RX-API-DMAC7.html)
CO (1) CO2022005947A2 (cg-RX-API-DMAC7.html)
IL (1) IL291953A (cg-RX-API-DMAC7.html)
MX (1) MX2022003883A (cg-RX-API-DMAC7.html)
TW (1) TWI897887B (cg-RX-API-DMAC7.html)
WO (1) WO2021072092A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12697305B2 (en) 2020-06-02 2026-08-04 R.P. Scherer Technologies, Llc Delayed release softgel capsules

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024525543A (ja) * 2021-07-06 2024-07-12 アール.ピー.シェーラー テクノロジーズ,エルエルシー 軟質ゲルカプセル剤
AU2021107198A4 (en) * 2021-08-24 2021-12-09 Blackmores Ltd A softgel capsule composition, and a process for producing a softgel capsule therefrom
CN119907662A (zh) * 2022-08-12 2025-04-29 R·P·谢勒技术有限公司 快速溶解软凝胶胶囊
EP4780423A1 (en) * 2023-09-18 2026-07-29 R.P. Scherer Technologies, LLC Fast dissolving softgel capsules including ibuprofen
CN121971400A (zh) * 2026-03-06 2026-05-05 广州琥瑞医药科技发展有限公司 一种硫酸氨基葡萄糖胶囊及其在预防运动损伤后关节退变中的应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH092522A (ja) * 1995-06-14 1997-01-07 Ono Toryo Hanbai Kk 角形缶群の緊締装置
JP3879941B2 (ja) * 1995-07-13 2007-02-14 エーザイ・アール・アンド・ディー・マネジメント株式会社 シームレスソフトカプセル
US6340473B1 (en) * 1999-07-07 2002-01-22 R.P. Scherer Technologies, Inc. Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
US6387400B1 (en) * 2000-08-29 2002-05-14 R.P. Scherer Technologies, Inc. Process for preparing pharmaceutical compositions for use with soft gelatin formulations
DE60238269D1 (de) * 2001-11-22 2010-12-23 Morishita Jintan Co Nicht-gelatinöse Kapseln
US7887838B2 (en) * 2002-01-18 2011-02-15 Banner Pharmacaps, Inc. Non-gelatin film and method and apparatus for producing same
EP1621211A1 (en) 2003-05-02 2006-02-01 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Soft capsule film and soft capsule
DE102005043172A1 (de) 2005-09-09 2007-03-15 Basf Ag Verfahren zur Herstellung von Weichkapselhüllen auf Basis von Polyvinylalkohol-Polyethylenglykol-Pfropfcopolymeren
US8900629B2 (en) * 2007-04-05 2014-12-02 University Of Kansas Rapidly dissolving pharmaceutical compositions comprising pullulan
JP5334727B2 (ja) 2009-07-28 2013-11-06 中日本カプセル 株式会社 ソフトカプセルの製造方法
CN101628117B (zh) * 2009-08-18 2011-02-16 北京航洋胶囊技术有限公司 一种咀嚼软胶囊皮、咀嚼软胶囊药物及其制备方法
JP5618402B2 (ja) * 2010-06-24 2014-11-05 三生医薬株式会社 咀嚼性ソフトカプセル剤の製造方法
JP6389237B2 (ja) * 2013-03-15 2018-09-12 パセオン ソフトジェルズ インコーポレイティド 非ゼラチン性腸溶性軟質カプセル
ES2692881T3 (es) * 2013-03-19 2018-12-05 Galenicum Health S.L. Composiciones farmacéuticas que comprenden un agente activo
US20150335586A1 (en) * 2014-05-20 2015-11-26 R.P. Scherer Technologies, Llc Capsule dispensing container
US9956292B2 (en) * 2014-08-13 2018-05-01 Cedars-Sinai Medical Center Anti-methanogenic compositions and uses thereof
CN106038508A (zh) * 2016-06-17 2016-10-26 上海春芝堂生物制品有限公司 一种植物囊壳材料、软胶囊及其制备方法、应用
HRP20250979T1 (hr) * 2017-04-14 2025-10-24 Capsugel Belgium Nv Pululan kapsule
WO2018225770A1 (ja) 2017-06-09 2018-12-13 富士カプセル株式会社 シームレスカプセル皮膜用組成物及びシームレスカプセル

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12697305B2 (en) 2020-06-02 2026-08-04 R.P. Scherer Technologies, Llc Delayed release softgel capsules

Also Published As

Publication number Publication date
TW202128134A (zh) 2021-08-01
AU2020363824A1 (en) 2022-04-14
CA3155876A1 (en) 2021-04-15
JP7727623B2 (ja) 2025-08-21
US20240091161A1 (en) 2024-03-21
CN114667084B (zh) 2024-11-15
JP2025148337A (ja) 2025-10-07
KR20220080130A (ko) 2022-06-14
MX2022003883A (es) 2022-07-19
IL291953A (en) 2022-06-01
BR112022005755A2 (pt) 2022-06-21
TWI897887B (zh) 2025-09-21
AR122316A1 (es) 2022-08-31
AU2020363824B2 (en) 2026-01-08
EP4041022A1 (en) 2022-08-17
EP4041022A4 (en) 2023-11-01
CN114667084A (zh) 2022-06-24
JP2022552223A (ja) 2022-12-15
WO2021072092A1 (en) 2021-04-15

Similar Documents

Publication Publication Date Title
MX2022003883A (es) Formulaciones en capsulas de gel blando de origen no animal, metodos de preparacion y metodos de uso de las mismas.
AU744704B2 (en) Aqueous viscous compositions, whether clear or not, for making soft or hard capsules, and method for making films for such capsules
DE60334924D1 (de) Anoteilchengrösse
US10596081B2 (en) Composition comprising gelled capsules stabilized by a buffer
BR0107874A (pt) Implante farmacêutico para controlavelmente liberar uma droga, método para controlavelmente liberar uma droga em um indivìduo, e, método para preparar o implante
AR029494A1 (es) Peliculas consumibles oralmente que se disuelven rapidamente que contienen una resina de intercambio de iones como agente que enmascara el sabor
JP2022535539A5 (cg-RX-API-DMAC7.html)
AR060234A1 (es) Gel de suspension espumable
BR0308866A (pt) Método para preparar cápsulas sem emenda, e, cápsula sem emenda
BR0213107A (pt) Composição de gel macio ou bastão geleificado para reduzir a umidade da axila
PT1809261E (pt) Sistema de cápsula mole não gelatinosa
BR112014024316B1 (pt) Cápsula mole que se desintegra no intestino grosso e seu método de produção
BR112012006651A2 (pt) cápsulas resistentes a ácido
DOP2012000217A (es) Pastillas de gelatina blanda con nicotina
CN1452481A (zh) 果胶膜组合物
ECSP044974A (es) Formulación de suspensión oral estabilizada
MXPA05008033A (es) Composiciones de milnacipran en forma de multiparticulas para administracion oral.
AR124044A1 (es) Cápsulas blandas de liberación retardada
IL276943B1 (en) Enteric softgel capsules
RU2018120693A (ru) Мягкие желатиновые капсулы с рН-независимым высвобождением
ES2610603T3 (es) Composiciones que contienen miel natural y método de preparación
JP2019023216A (ja) 硬カプセル製剤
AR122512A1 (es) Cápsulas blandas de liberación retardada
JP2023532180A5 (cg-RX-API-DMAC7.html)
AR043536A1 (es) Composicion farmaceutica que comprende acido 5-metil-2-(2´-cloro-6´-fluoroanilino)fenilacetico